Statistics for Autolus Therapeutics PLC (id:8133 AUTL)

Valuation metrics

Market cap

745.14M

Enterprise value

429.05M

Trailing P/E (ttm)

-2.33

Forward P/E

-3.84

PEG ratio

-3.84

Price/Sales (ttm)

73.84

Price/Book (mrq)

1.56

Enterprise Value/Revenue

42.52

Enterprise Value/EBITDA

-2.08

Overview

Shares outstanding

266.12M

Float

131.57M

Shares short

7.19M

% Held by insiders

0.18%

% Held by institutions

0.76%

Average volume (10 days)

2.62M

Average volume (90 days)

Price summary

52-Week low

2.74

52-Week high

7.45

52-Week change

-71.43%

Beta

2.04

50-Day moving average

3.88

200-Day moving average

4.50

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,113.54%

Operational effectiveness

Return on assets

-21.61%

Return on equity

-82.20%

Income statement

Revenue (ttm)

0.04

Revenue per share (ttm)

0.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-205,863,008.00

Net income to common (ttm)

-270,227,008.00

Diluted EPS (ttm)

-1.22

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

657.07M

Total cash per share (mrq)

2.47

Total debt (mrq)

301.17M

Total Debt/Equity (mrq)

63.14

Current ratio (mrq)

1.37K%

Book value per share (mrq)

1.79

Cash flow

Cash flow statement

-193,170,000.00

Levered free cash flow (LFCF)

-171,182,752.00